GREY:ATBPF - Post by User
Post by
MasterAlgaeon Oct 24, 2020 11:03am
290 Views
Post# 31776474
Glaxo Big name partner rumor
Glaxo Big name partner rumorGlaxoSmithKline has one drug in Phase 1 for osteoarthritis pain. Very early stages - no name yet just a number. See their 2019 annual report.
Tanezumab (anti-nerve growth factor drug) - is collaberation between Pfizer Eli Lilly & Co. and is being tested for osteoarthritis pain, and for other pain like lower back and cancer pain.
According to an Oct 14th article by Motly Fool "The company currently awaits regulatory approvals for four programs, including new pain drug tanezumab."
According to an Oct 16th article by Zacks "A notable pipeline candidate in Lily’s [sic] portfolio for the pain indication is tanezumab. It is being developed in a late-stage study for osteoarthritis pain and is currently under review in the United States and Europe for the given indication. It is also being evaluated in a phase III study for treating cancer pain."
Doubtful that Pfizer and Lilly would cannabilize years of research to get Oten...
So Glaxo?